SCIENTIFIC BACKGROUND

AARS, ACTL6B, ADAM22, ADGRV1, ADRA2B, ALDH7A1, ALG13, AP3B2, ARHGEF15, ARHGEF9, ARV1, ARX, ATP1A2, BRAT1, CACNA1A, CACNA1E, CACNA1H, CACNB4, CAD, CASR, CDKL5, CERS1, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CLCN4, CNPY3, CNTN2, CPA6, CPLX1, CSTB, CYFIP2, DCX, DENND5A, DEPDC5, DNM1, DOCK7, DYRK1A, EEF1A2, EFHC1, EPM2A, FGF12, FOXG1, FRRS1L, GABBR2, GABRA1, GABRA2, GABRA5, GABRB1, GABRB2, GABRB3, GABRD, GABRG2, GAL, GLS, GLUL, GNAO1, GOSR2, GPHN, GRIN2A, GRIN2B, GRIN2D, GUF1, HCN1, HDAC4, HNRNPU, IQSEC2, ITPA, KCNA1, KCNA2, KCNB1, KCNC1, KCNH5, KCNMA1, KCNQ2, KCNQ3, KCNT1, KCNT2, KCTD7, LGI1, LMNB2, MBD5, MDH2, MECP2, MEF2C, NECAP1, NEUROD2, NHLRC1, NPRL2, NPRL3, NTRK2, PARS2, PCDH19, PHACTR1, PIGA, PIGB, PIGP, PIGQ, PLCB1, PLPBP, PNKP, PNPO, POLG, PPP3CA, PRDM8, PRICKLE1, PRICKLE2, PRRT2, RANBP2, RANGAP1, RELN, RHOBTB2, RNF13, ROGDI, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SIK1, SLC12A5, SLC13A5, SLC1A2, SLC25A12, SLC25A22, SLC2A1, SLC35A2, SLC6A1, SPTAN1, SRPX2, ST3GAL3, STX1B, STXBP1, SYNGAP1, SYNJ1, SZT2, TBC1D24, UBA5, WWOX, YWHAG

Epilepsies occur with a frequency of 0.5 to 1%, and almost half of them are begin in childhood. In the heterogeneous group of epilepsies at least 50% are genetically determined, and in most cases, caused by polygenic or multifactorial factors. Only 1 to 2% of so-called idiopathic epilepsies have monogenic inheritance. These include epileptic encephalopathies of childhood (EIEE), which start early in life, take on a severe course, are often difficult to treat and show comorbidities in addition to the existing cognitive development delay which is almost always present. In idiopathic generalized epilepsies, the detection of a pathogenic variant in one of the listed genes often indicates that there is an increased risk of developing epilepsy (known as susceptibility factors). A large proportion of hereditary epilepsies are caused by pathogenic variants in subunits of neuronal voltage-dependent sodium (Na+), potassium (K+), calcium (Ca2+) or chloride (Cl-) ion channels and subunits of ligand-dependent receptors such as the GABAA receptor and the nicotine acetyl choline receptor.

 

Genetic epilepsies can be compared with symptomatic epilepsies which occur as a consequence of a congenital brain malformation (e.g., migration disorder). They can also occur in the context of other genetic syndromes (e.g., Angelman syndrome, Rett syndrome, tuberous sclerosis) or in the case of chromosomal imbalances.

 

Clinical differential diagnosis can often be difficult, which is why genetic diagnostics—also by means of NGS—is becoming increasingly useful for clarifying the cause(s). The detection of a pathogenic variant can confirm a suspected diagnosis, which may lead to a targeted therapy (e.g., glucose transporter defect). In addition, further diagnostics can be avoided, and a prognostic assessment and statements on a possible risk of recurrence can be provided.

 

References

Myers et al. 2019, Clin Genet 95(1):95 / Scheffer et al. 2017, Epilepsia; 58(4):512 / Lesca et al. 2015, Rev Neurol (Paris) 6-7:539 / Poduri et al. 2014, Nat Rev Neurol 10(5):293 / Scheffer 2014, Neuropediatrics 45:70 / Thomas et al. 2014, Nat Rev Neurol 10:283 / Thomas et al. 2014, Nat Rev Neurol 10:283 / Hoppman-Chaney et al. 2012, Clin Genet 83:345 / Tavyev Asher et al. 2012, Eur J Med Genet 55:299 / Striano et al. 2012, Arch Neurol 69:322 / Noh et al. 2012, Eur J Med Genet 55:281 / Weber et al. 2011, Z Epileptol 24:100 / Nicita et al. 2011, Seizure 21:3 / Muhle et al. 2011, Epilepsia 52:e194 / Depienne et al. 2010, Hum Mut 32:E1959 / Berg et al. 2010, Akt Neurol 37:120 / OMIM, Online Mendelian Inheritance In Man

GENES

AARS, ACTL6B, ADAM22, ADGRV1, ADRA2B, ALDH7A1, ALG13, AP3B2, ARHGEF15, ARHGEF9, ARV1, ARX, ATP1A2, BRAT1, CACNA1A, CACNA1E, CACNA1H, CACNB4, CAD, CASR, CDKL5, CERS1, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CLCN4, CNPY3, CNTN2, CPA6, CPLX1, CSTB, CYFIP2, DCX, DENND5A, DEPDC5, DNM1, DOCK7, DYRK1A, EEF1A2, EFHC1, EPM2A, FGF12, FOXG1, FRRS1L, GABBR2, GABRA1, GABRA2, GABRA5, GABRB1, GABRB2, GABRB3, GABRD, GABRG2, GAL, GLS, GLUL, GNAO1, GOSR2, GPHN, GRIN2A, GRIN2B, GRIN2D, GUF1, HCN1, HDAC4, HNRNPU, IQSEC2, ITPA, KCNA1, KCNA2, KCNB1, KCNC1, KCNH5, KCNMA1, KCNQ2, KCNQ3, KCNT1, KCNT2, KCTD7, LGI1, LMNB2, MBD5, MDH2, MECP2, MEF2C, NECAP1, NEUROD2, NHLRC1, NPRL2, NPRL3, NTRK2, PARS2, PCDH19, PHACTR1, PIGA, PIGB, PIGP, PIGQ, PLCB1, PLPBP, PNKP, PNPO, POLG, PPP3CA, PRDM8, PRICKLE1, PRICKLE2, PRRT2, RANBP2, RANGAP1, RELN, RHOBTB2, RNF13, ROGDI, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SIK1, SLC12A5, SLC13A5, SLC1A2, SLC25A12, SLC25A22, SLC2A1, SLC35A2, SLC6A1, SPTAN1, SRPX2, ST3GAL3, STX1B, STXBP1, SYNGAP1, SYNJ1, SZT2, TBC1D24, UBA5, WWOX, YWHAG

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Mosaicism is a biological phenomenon in which a person has two or more genetically different sets of cells. Although mosaicism may have no effect, it...

Read more

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more